ArticleFoods (Basel, Switzerland)2026
Development of Bacterial Cellulose-Based Films Incorporated with Epigallocatechin-3-Gallate for Active Food Packaging.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Research Progress of Composite Films in Postharvest Preservation of Fruits and Vegetables.Molecules (Basel, Switzerland) · 2026Review
- Antibacterial Packaging for Cheese Based on Carboxymethyl Cellulose Composite with Zinc Oxide and Thyme Essential Oil.Foods (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Recently, renewable biopolymers have gained growing attention as an alternative to petroleum-based materials in the packaging industry due to their eco-friendliness, biodegradability, and biocompatibility. This study introduces an innovative method for producing active films, which uses natural bacterial cellulose (BC) films as the matrix and incorporates (-)-Epigallocatechin-3-gallate (EGCG) through an immersion process. The incorporation of EGCG improves the barrier performance against oxygen and UV of the BC-based active films while preserving their tensile strength without compromising their opacity. More importantly, the active films exhibited significant antibacterial effects, with the efficacy increasing with the concentration of EGCG. Specifically, the diameters of the inhibition zones enlarged progressively against both
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.